Table 1.
Prevalence of various autoantibodies in the serum of the participants according to gender: N(%)
| Autoantibody | Total (n = 152) | Men (n = 92) | Women (n = 60) | Difference men versus women |
|---|---|---|---|---|
| Anti-TPO | 0 (0) | 0 (0) | 0 (0) | n.s. |
| Anti-Tm | 0 (0) | 0 (0) | 0 (0) | n.s. |
| Anti-Tg | 0 (0) | 0 (0) | 0 (0) | n.s. |
| RF | 57 (38) | 27 (29) | 30 (50) | P = 0·016 |
| ANA | 14 (9) | 10 (11) | 4 (7) | ns |
| Anticentromere | 0 (0) | 0 (0) | 0 (0) | n.s. |
| Anti ds-DNA | 0 (0) | 0 (0) | 0(0) | ns |
| Anti-ENA | 0 (0) | 0 (0) | 0 (0) | ns |
| Anti-SMA | 14 (9) | 4 (4) | 10 (17) | P = 0·023 |
| Anti-MA | 1 (1) | 0 (0) | 1 (2) | n.s. |
| Anti-IF | 11 (7) | 9 (10) | 2 (3) | n.s. |
| Anti-PCA | 0 (0) | 0 (0) | 0 (0) | n.s. |
TPO, thyroid peroxidase; Tm, thyroid microsome; Tg, thyroglobulin; RF, rheumatoid factor; ANA, antinuclear antibody; ENA, extractable nuclear antigen; SMA, smooth muscle antibody; MA, mitochondrial antibody; IF, intrinsic factor; PCA, parietal cell antibody; n.s., not significant.